(HealthDay)—Basal insulin analogues for type 2 diabetes mellitus (T2DM) do not substantially differ in their glucose-lowering effect, according to a review published online July 10 in the Annals of Internal Medicine.
Jul 18, 2018
0
0
(HealthDay)—For young adults with type 1 diabetes, there are differences in arrhythmic risk and cardiac repolarization during nocturnal versus daytime hypoglycemia, according to a study published online Feb. 17 in Diabetes ...
Feb 28, 2017
0
0
(HealthDay)—Nocturnal hypoglycemia is associated with reduced awakening response, according to a study published online Sept. 25 in Diabetes Care.
Oct 1, 2015
0
6
(HealthDay)—For patients with type 1 diabetes and documented nocturnal hypoglycemia, insulin-pump therapy with a threshold-suspend feature reduces nocturnal hypoglycemia over a three-month period, according to a study published ...
Jun 24, 2013
0
0
(HealthDay)—For patients with type 1 diabetes, the novel, long-acting basal insulin LY2605541 yields greater improvement in glycemic control compared with insulin glargine, according to a study published online Nov. 27 ...
Jan 13, 2013
0
0
(HealthDay) -- For adults with type 1 diabetes there is a marked decrease in the low-frequency component of heart rate variability during spontaneous nocturnal hypoglycemia, according to a study published online May 18 in ...
Jun 1, 2012
0
0
Using an automated insulin feedback controller as part of an overnight closed-loop (OCL) control system improved glucose control (increased time within target glucose range) and reduced episodes of nocturnal hypoglycemia ...
Jun 7, 2016
0
2
